1. Home
2. Our Speakers
3. Dr Nur Ozyilmaz

Dr Nur Ozyilmaz

Dr. Nur Ozyilmaz is a former NHS Consultant, trained in the UK and with over twenty-five years of experience in medicine.

She initially worked in emergency medicine for six years before specialising in paediatrics and later nephrology, receiving comprehensive medical training at prestigious institutions in London such as Kings College, Great Ormond Street, and St Thomas' Hospital. Following this, she pursued further postgraduate studies in the USA in regenerative and integrative medicine with a special interest in Hyperbaric Oxygen therapy.

Through her personal journey and firsthand experience, she became deeply passionate about hyperbaric oxygen medicine. In 2019, she founded NUMA with the mission to provide outstanding hyperbaric oxygen therapy services. Since then, she has been collaborating with referring physicians and distinguished healthcare professionals to design personalised hyperbaric oxygen therapy programs grounded in her clinical expertise and the latest research. 

Talk Overview

The Use of Hyperbaric Oxygen Therapy in Regenerative Medicine

Dr Nur will be talking about Hyperbaric Oxygen Therapy and Its Applications in Regenerative Medicine

Hyperbaric oxygen therapy has been approved for clinical use in 14 different conditions by the regulatory authorities and has been used clinically since the 1950s.

HBOT has primarily been used to treat non-healing wounds and certain life-threatening conditions. In addition to its established clinical uses, hyperbaric oxygen therapy is gaining attention for its potential benefits in wider medical conditions, as well as regenerative and anti-aging medicine. As more health-conscious individuals express interest in incorporating HBOT into their wellness regimes, the therapy's emerging indications are being further explored.

This presentation will examine the scientific evidence on how hyperbaric oxygen therapy is purported to significantly impact the pathophysiological effects of aging and analyse the proposed mechanisms, including reducing senescent cells, increasing elastic fiber length and stability, enhancing collagen density and angiogenesis, stimulating stem cells and growth factors, and modulating cell senescence and telomere shortening.

The presentation will also include a brief overview of how hyperbaric oxygen therapy can be applied managing vascular occlusion from fillers.